USC will also be inspected by the U.S. Centers for Medicare and Medicaid Services (CMS), which is conducting a review of all federally-funded liver transplant programs after two other California facilities failed to meet federal standards in 2005. CMS is the agency responsible for certifying hospitals to receive reimbursement for treatment of Medicare and Medicaid patients. The federal program demands a 77 % survival rate for liver transplant patients for the hospital program to qualify for certification.

Have you been harmed by USC's Liver Transplant Program ? You may have a lawsuit. Click here, for a top rated law firm to evaluate your legal rights. [Sponsored Link]

Dr. John R. Lake, head of liver transplantation at the University of Minnesota Medical Center and the chair of the liver and intestinal organ transplantation committee of the United Network for Organ Sharing (UNOS) predicted in a recent L.A. Times article that UNOS will also investigate. UNOS is the federal contractor responsible for overseeing organ transplant programs.

In 2005, St. Vincent’s hospital in Los Angeles became the first liver transplant program to be sanctioned by CMS. CMS withdrew federal certification for reimbursement on September 30, 2005 and the hospital suspended the program. That investigation began when CMS discovered that a patient who was 52 on a regional list was given a liver in 2003, while the patient who was at the top of the list was removed from the list, but told that he was still eligible for a liver. The investigation that followed this report revealed that St. Vincent’s program failed to qualify for federal funding because of 8 conditions unrelated to the scandal, including inadequate record keeping and inadequate review of candidates for liver transplants. In June 2006, CMS approved St. Vincent’s plan for restructuring the program but declined to certify the program again until the hospital shows it is following through on the plan.

In November 2005, another Southern California liver-transplant center in Orange County run by the University of California at Irvine (UCI) was suspended after a UNOS inspection. UNOS initiated that inspection after a complaint from a patient who had been waiting for years to receive a liver, and the inspection showed 7 deficiencies in the program. UCI had turned down most of the livers offered to it for transplantation because of a shortage of surgeons, but failed to tell the patients that livers were being refused. The one-year survival rate for liver-transplant patients at UCI was only 68–70 %, and 30 patients died in a two-year period while waiting for liver transplants.

For more information about this and other liver transplant investigations in California, see USC’s Liver Transplant Patients Show Low Survival Rate and More Problems for California’s Transplant Programs: Is USC Next in Line for Transplant Lawsuits?. For a free evaluation of your personal injury, wrongful death, or medical malpractice case, you can fill out our case evaluation form. To find a personal injury attorney, wrongful death lawyer, or medical malpractice attorney, check out AttorneyPages.com.

Have you been harmed by USC's Liver Transplant Program ? You may have a lawsuit. Click here, for a top rated law firm to evaluate your legal rights. [Sponsored Link]